SILVANA DE CASTRO FARIA to Janus Kinase 2
This is a "connection" page, showing publications SILVANA DE CASTRO FARIA has written about Janus Kinase 2.
Connection Strength
0.074
-
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes. J Clin Oncol. 2012 Nov 20; 30(33):4161-7.
Score: 0.074